Targeting Epigenetics for Treatment of BRAF Mutated Metastatic Melanoma With Decitabine in Combination With Vemurafenib: A Phase Lb Study
Oncotarget - United States
doi 10.18632/oncotarget.21269
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 26, 2017
Authors
Publisher
Impact Journals, LLC